T. Ischinger

发表

Does Length or Eccentricity of Coronary Stenoses Influence the Outcome of Transluminal Dilatation?

B Meier, B. Meier, A. Gruentzig, 1983, Circulation.

The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer.

F. Eberli, P. Serruys, P. Jüni, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

The Cardiac Catheterization Laboratory for Coronary Angioplasty

U. Aker, T. Ischinger, 1986 .

Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial

J. Pepper, S. Pocock, M. Pfisterer, 2002, The Lancet.

Factors Influencing the Rate of Coronary Artery Occlusion and Reocclusion

T. Ischinger, 1989 .

Indications and Contraindications for Coronary Angioplasty

T. Ischinger, 1986 .

Atrial Pacing During Percutaneous Transluminal Coronary Angioplasty: Results and Comparison with Exercise Treadmill Testing

H. Kennedy, H. Stratmann, U. Aker, 1987, Angiology.

Practice of Coronary Angioplasty

T. Ischinger, Thomas Ischinger, 1986, Springer Berlin Heidelberg.

Assessment of Results of Coronary Angioplasty

B. Meier, T. Ischinger, 1986 .

Technique of PTCA — Femoral Approach

T. Ischinger, 1986 .

Late progression of an asymptomatic intimal tear to occlusive coronary artery dissection following angioplasty.

T. Ischinger, P. Zack, 1985, Catheterization and cardiovascular diagnosis.

Optimizing the Outcome of Carotid Stenting: Which Stent, Technique and Drug?

T. Ischinger, 2004 .

Carotid stenting: which stent for which lesion?

T. Ischinger, 2001, Journal of interventional cardiology.

Percutaneous transluminal coronary angioplasty in patients with prior coronary bypass surgery.

B. Meier, E. Jones, J. Douglas, 1983, Journal of the American College of Cardiology.

The Problem of Restenosis

J. Hollman, T. Ischinger, 1986 .

Outcome of Coronary Angioplasty

B. Meier, T. Ischinger, 1986 .

Chapter 12. The Problem of Restenosis

J. Hollman, T. Ischinger, 1986 .

Coronary dissection and total coronary occlusion associated with percutaneous transluminal coronary angioplasty: significance of initial angiographic morphology of coronary stenoses.

B. Meier, A. Gruentzig, T. Ischinger, 1986, Circulation.

Evaluation of the Coronary Arteriogram in Selection of Patients for Coronary Angioplasty

T. Ischinger, 1986 .

Significance of the Angiographic Coronary Morphology for the Early Outcome of PTCA

T. Ischinger, 1986 .

Aortic valve calcium score as a predictor for outcome after TAVI using the CoreValve revalving system.

T. Helmberger, A. Huber, E. Hoffmann, 2013, International journal of cardiology.

Clinical Selection Criteria and Role of Noninvasive Testing for PTCA

B. Chaitman, H. Goodgold, T. Ischinger, 1986 .

13-year follow-up of the German angioplasty bypass surgery investigation.

T. Meinertz, C. Hamm, R. Hoffmann, 2005, European heart journal.

13-year follow-up of the German angioplasty bypass surgery investigation

T. Meinertz, C. Hamm, R. Hoffmann, 2005 .

Improved outcome with novel device for low-pressure PTCA in de novo and in-stent lesions.

T. Ischinger, R. Solar, E. Hitzke, 2003, Cardiovascular radiation medicine.

Relation of Elevated C-Reactive Protein and Interleukin-6 Levels to Left Atrial Size and Duration of Episodes in Patients With Atrial Fibrillation

R. Kronmal, W. Bleifeld, J. Reimers, 2005 .

Original Article A prospective, non-randomized comparison of SAPIEN XT and CoreValve implantation in two sequential cohorts of patients with severe aortic stenosis

A. Kastrati, E. Hoffmann, A. Leber, 2014 .

A prospective, non-randomized comparison of SAPIEN XT and CoreValve implantation in two sequential cohorts of patients with severe aortic stenosis.

A. Kastrati, E. Hoffmann, A. Leber, 2014, American journal of cardiovascular disease.

Angiographic follow-up results of a randomized study on angioplasty versus bypass surgery (GABI trial). GABI Study Group.

C. Hamm, H. Rupprecht, J. Meyer, 1996, European heart journal.

Successful Thrombectomy in Severely Diseased Vein Graft Prior to Stent placement

T. Ischinger, 2004 .

Recent Stent Occlusion: Successful Use of X-Sizer Thrombectomy

T. Ischinger, 2004 .

The impact of body mass index on the one year outcomes of patients treated by percutaneous coronary intervention with Biolimus- and Sirolimus-eluting stents (from the LEADERS Trial).

Dick M. Goedhart, F. Eberli, P. Serruys, 2010, The American journal of cardiology.

Angiographic outcome after intracoronary X‐Sizer helical atherectomy and thrombectomy: First use in humans

J. Popma, D. Mathey, T. Ischinger, 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Partial malposition of PFO closure device: indication for elective surgical removal?

T. Ischinger, B. Kemkes, C. Boosfeld, 2003, Zeitschrift für Kardiologie.

Higher balloon dilatation pressure in coronary angioplasty.

B. Meier, J. Douglas, S. King, 1984, American heart journal.

The occurrence of angiographically detected intracoronary thrombus in patients with unstable angina pectoris.

H. Kennedy, B. Dincer, U. Aker, 1984, American heart journal.

First generation versus second generation drug‐eluting stents for the treatment of bifurcations: 5‐year follow‐up of the LEADERS all‐comers randomized trial

F. Eberli, P. Serruys, R. D. de Winter, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudy.

F. Eberli, P. Serruys, J. Wykrzykowska, 2009, JACC. Cardiovascular interventions.

Efficacy and safety of a new hemostatic wound dressing following diagnostic heart catheterization

E. Hoffmann, D. Antoni, T. Ischinger, 2012 .

Experience with a technique for coronary angioplasty of bifurcational lesions.

T. Ischinger, P. Zack, 1984, Catheterization and cardiovascular diagnosis.

A RANDOMIZED STUDY OF CORONARY ANGIOPLASTY COMPARED WITH CORONARY BYPASS SURGERY

C. Hamm, J. Reimers, T. Ischinger, 1994 .

Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the "all-comers" LEADERS trial.

F. Eberli, P. Serruys, J. Wykrzykowska, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

PATHOPHYSIOLOGY AND NATURAL HISTORY PTCA

B. Meier, J. Douglas, S. King, 2005 .

Complex Catheter-Based Treatment: Coronary and Carotid Stenting and Mitral Balloon Valvuloplasty

T. Ischinger, 2004 .

Introduction and Historical Background

T. Ischinger, 1986 .

Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease Final 5-Year Report (Limus Eluted From A Durable Versus ERodable Stent Coating) Randomi

F. Eberli, P. Serruys, S. Windecker, 2022 .

Acute occlusion after percutaneous transluminal coronary angioplasty--a new approach.

B. Meier, J. Douglas, S. King, 1983, Circulation.

A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI)

C. Hamm, H. Rupprecht, W. Bleifeld, 1994, The New England journal of medicine.

[Reuse of "single use" medical devices after quality assured reprocessing: hygienic, legal and economic aspects. Potential for cost savings in interventional cardiology].

H. Schätzl, M. Bock, T. Ischinger, 2002, Zeitschrift fur Kardiologie.

Ameet Bakhai, William Wijns, Jean Booth, 2002, The Lancet.

Value of Age, Creatinine, and Ejection Fraction (ACEF Score) in Assessing Risk in Patients Undergoing Percutaneous Coronary Interventions in the ‘All-Comers' LEADERS Trial

Dick M. Goedhart, F. Eberli, P. Serruys, 2011, Circulation. Cardiovascular interventions.

Focused force angioplasty: theory and application.

T. Ischinger, R. Solar, 2003, Cardiovascular radiation medicine.

Antithrombotics in interventional cardiology: optimizing treatment and strategies.

T. Ischinger, 1998, The American journal of cardiology.

Angioplasty Equipment and Supplies: Technical Considerations

T. Ischinger, M. Vandormael, R. Roth, 1986 .

Immediate and short-term benefit of multilesion coronary angioplasty: influence of degree of revascularization.

H. Kennedy, B. Chaitman, U. Aker, 1985, Journal of the American College of Cardiology.

Repeat coronary angioplasty.

B Meier, B. Meier, J. Douglas, 1984, Journal of the American College of Cardiology.

Risk of side branch occlusion during coronary angioplasty.

B Meier, B. Meier, J. Douglas, 1984, The American journal of cardiology.

Should coronary arteries with less than 60% diameter stenosis be treated by angioplasty?

B. Meier, J. Douglas, S. King, 1983, Circulation.

Laser Angioplasty: State of the Art after 10 Years of Clinical Research

T. Ischinger, 1992 .

Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial.

F. Eberli, P. Serruys, J. Wykrzykowska, 2010, Journal of the American College of Cardiology.

FX MiniRAIL catheter usage for treatment of de novo complex coronary lesions: results from the "OFFAR".

M. Mosseri, R. Kornowski, A. Colombo, 2006, Journal of interventional cardiology.

The outcome of bifurcation lesion stenting using a biolimus-eluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer.

F. Eberli, P. Serruys, J. Wykrzykowska, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

F. Eberli, P. Serruys, S. Windecker, 2008, The Lancet.

The Role of the Cardiothoracic Surgeon in PTCA

G. Kaiser, L. McBride, T. Ischinger, 1986 .

Glycoprotein IIb/IIIa antagonists during carotid artery stenting:

H. Mudra, M. Hochadel, K. Hauptmann, 2007, Clinical Research in Cardiology.

Acute coronary occlusion during balloon angioplasty due to intracoronary thrombus and coronary spasm: a reversible complication.

U. Aker, T. Ischinger, P. Zack, 1984, American heart journal.

Embolic protection devices for carotid artery stenting: better results than stenting without protection?

N. Niedermaier, K. Hauptmann, J. Senges, 2004, European heart journal.

Comparison of zotarolimus-eluting and everolimus-eluting coronary stents.

Volker Klauss, Patrick W Serruys, William Wijns, 2010, The New England journal of medicine.

Carotid artery stenting in clinical practice

M. Hochadel, K. Hauptmann, U. Zeymer, 2005, Zeitschrift für Kardiologie.

Carotid artery stenting: Do procedural complications relate to the side intervened upon?

H. Mudra, M. Hochadel, K. Hauptmann, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial

F. Eberli, P. Serruys, S. Windecker, 2011, The Lancet.

The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutan

P. Serruys, S. Silber, S. Windecker, 2011, Journal of the American College of Cardiology.

Carotid artery stenting in octogenarians: results from the ALKK Carotid Artery Stent (CAS) Registry.

H. Mudra, M. Hochadel, K. Hauptmann, 2007, European heart journal.

Carotid artery interventions for restenosis after prior stenting: is it different from interventions of de novo lesions? Results from the carotid artery stent (CAS)—registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK)

J. Brachmann, H. Mudra, K. Hauptmann, 2010, Clinical Research in Cardiology.

Comparison of in-hospital outcomes of patients with versus without previous carotid endarterectomy undergoing carotid stenting (from the German ALKK CAS Registry).

M. Hochadel, R. Mehta, K. Hauptmann, 2007, The American journal of cardiology.

The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial.

P. Serruys, S. Silber, J. Wykrzykowska, 2011, JACC. Cardiovascular interventions.

The three year follow-up of the randomised "all-comers" trial of a biodegradable polymer biolimus-eluting stent versus permanent polymer sirolimus-eluting stent (LEADERS).

F. Eberli, P. Serruys, J. Wykrzykowska, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer.

F. Eberli, P. Serruys, S. Garg, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

2-year clinical follow-up from the randomized comparison of biolimus-eluting stents with biodegradable polymer and sirolimus-eluting stents with durable polymer in routine clinical practice.

F. Eberli, P. Serruys, P. Wenaweser, 2011, JACC. Cardiovascular interventions.

Biolimus-eluting biodegradable polymer versus sirolimus-eluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudy.

F. Eberli, P. Serruys, L. Räber, 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

VALUE OF THE SYNTAX SCORE (SX) FOR RISK ASSESSMENT IN THE “ALL-COMERS” POPULATION OF THE RANDOMIZED MULTICENTER LEADERS TRIAL.

F. Eberli, P. Serruys, J. Wykrzykowska, 2010 .

Outcomes Following Elective Percutaneous Coronary Intervention Without On-Site Surgical Backup in a Community Hospital

S. Saito, K. Tanabe, S. Hofma, 2005 .

TCT-44 LEADERS: 5-Year Follow-Up from a Prospective, Randomized Trial of Biolimus A9-Eluting Stents with a Biodegradable Polymer vs. Sirolimus-Eluting Stents with a Durable Polymer- Final report of the LEADERS study

F. Eberli, P. Serruys, S. Windecker, 2012 .

Embolic protection devices for carotid artery stenting: is there a difference between filter and distal occlusive devices?

K. Hauptmann, J. Senges, U. Tebbe, 2005, Journal of the American College of Cardiology.

Effectiveness and safety of carotid artery stenting for significant carotid stenosis in patients with contralateral occlusion (from the German ALKK-CAS Registry experience).

H. Mudra, M. Hochadel, R. Mehta, 2009, The American journal of cardiology.

Effect of stent design on reduction of elastic recoil: A comparison via quantitative intravascular ultrasound

A. Arbab-Zadeh, Yoshito Yamamoto, D L Brown, 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

P. Serruys, S. Silber, S. Windecker, 2011, Journal of the American College of Cardiology.

Aortic valve calcium score as a predictor for outcome after TAVI using the CoreValve revalving system.

T. Helmberger, A. Huber, E. Hoffmann, 2013, International journal of cardiology.

THERAPY AND PREVENTION

A. Gruentzig, T. Ischinger, K. Galan, 2005 .

Embolic protection devices for carotid artery stenting: is there a difference between filter and distal occlusive devices?

K. Hauptmann, J. Senges, U. Tebbe, 2005, Journal of the American College of Cardiology.

Embolic protection devices for carotid artery stenting: better results than stenting without protection?

N. Niedermaier, K. Hauptmann, J. Senges, 2004, European heart journal.

The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer.

F. Eberli, P. Serruys, M. Joner, 2010 .

Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent

M. Morice, W. Wijns, P. Buszman, 2013, JACC. Cardiovascular interventions.

[The effect of intravenous nifedipine administration on coronary occlusion during coronary angioplasty on ischemia tolerance and collateral function].

W. Delius, D. Antoni, T. Ischinger, 1990, Zeitschrift fur Kardiologie.